Literature DB >> 28616273

Mid- to long-term outcomes of bovine jugular vein conduit implantation in Chinese children.

Hui-Feng Zhang1, Gang Chen1, Ming Ye1, Xian-Gang Yan1, Qi-Lin Tao1, Bing Jia1.   

Abstract

BACKGROUND: Bovine jugular vein (BJV) conduits are widely applied for surgical reconstruction of the right ventricular outflow tract (RVOT). However, relevant studies of valve failure rates and the related risk factors are limited in China. The aim of this study was to assess the BJV prognosis after medium- to long-term follow-up.
METHODS: Fifty-three hospital patients implanted with BJV conduits from January 2002 to December 2013 were recruited. Patient information and follow-up prognosis were reviewed retrospectively. Conduit stenosis and failure as well as endocarditis were diagnosed.
RESULTS: The total person years was 345.5, and the median follow-up time was 6.3 years. Early mortality occurred in two patients, and there was no late mortality. BJV conduit failure occurred in 15 patients (29.4%) due to severe stenosis (n=10), stenosis plus regurgitation (n=3), and regurgitation alone (n=2). The proportion of patients who were free of BJV conduit failure at 1, 3, 5, and 7 years was 98.0%, 85.8%, 76.8%, and 62.1%, respectively. There were nine cases of endocarditis (17.0%). Multivariate logistic regression analysis showed that endocarditis was a significant risk factor associated with BJV conduit failure (OR: 6.735; 95% CI: 1.348-33.647).
CONCLUSIONS: The durability of BJV conduits was suboptimal after a mid-term follow-up period. Endocarditis was found to be a significant risk factor that accelerates BJV conduit deterioration.

Entities:  

Keywords:  Bovine jugular vein conduit; conduit failure; endocarditis; right ventricular outflow tract reconstruction

Year:  2017        PMID: 28616273      PMCID: PMC5465117          DOI: 10.21037/jtd.2017.05.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  20 in total

1.  Does contegra xenograft implantation evoke cellular immunity in children?

Authors:  Michal Wojtalik; Wojciech Mrowczynski; Jan Zeromski; Rafal Bartkowski
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-09

2.  Use of extra corporeal membrane oxygenation in the management of sepsis secondary to an infected right ventricle-to-pulmonary artery Contegra conduit in an adult patient.

Authors:  Hunaid A Vohra; Ceri Jones; Nicola Viola; Marcus P Haw
Journal:  Interact Cardiovasc Thorac Surg       Date:  2008-11-10

3.  Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of fallot or pulmonary atresia associated with ventricular septal defect.

Authors:  Kevin Ong; Robert Boone; Min Gao; Ron Carere; John Webb; Marla Kiess; Jasmine Grewal
Journal:  Am J Cardiol       Date:  2013-03-04       Impact factor: 2.778

4.  Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age?†.

Authors:  Keti Vitanova; Julie Cleuziou; Jürgen Hörer; Jelena Kasnar-Samprec; Manfred Vogt; Christian Schreiber; Rüdiger Lange
Journal:  Eur J Cardiothorac Surg       Date:  2014-03-09       Impact factor: 4.191

5.  Bovine jugular vein valved conduit: up to 10 years follow-up.

Authors:  Natasha Prior; Nelson Alphonso; Philip Arnold; Ian Peart; Kent Thorburn; Prem Venugopal; Antonio F Corno
Journal:  J Thorac Cardiovasc Surg       Date:  2010-09-29       Impact factor: 5.209

6.  Bovine valved venous xenograft in pulmonary position: medium term evaluation of risk factors for dysfunction and failure after 156 implants.

Authors:  G Palma; V A Mannacio; G Mastrogiovanni; V Russolillo; S Cioffi; M Mucerino; C Vosa
Journal:  J Cardiovasc Surg (Torino)       Date:  2011-04       Impact factor: 1.888

7.  Mid-term experience with the Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction.

Authors:  André Rüffer; Johannes Wittmann; Sergej Potapov; Ariawan Purbojo; Martin Glöckler; Andreas Max Koch; Sven Dittrich; Robert Anton Cesnjevar
Journal:  Eur J Cardiothorac Surg       Date:  2012-04-03       Impact factor: 4.191

8.  Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation.

Authors:  Sophie Malekzadeh-Milani; Magalie Ladouceur; Laurence Iserin; Damien Bonnet; Younes Boudjemline
Journal:  J Thorac Cardiovasc Surg       Date:  2014-08-09       Impact factor: 5.209

9.  Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement.

Authors:  Carlos M Mery; Francisco A Guzmán-Pruneda; Luis E De León; Wei Zhang; Matthew D Terwelp; Claire E Bocchini; Iki Adachi; Jeffrey S Heinle; E Dean McKenzie; Charles D Fraser
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-27       Impact factor: 5.209

10.  Determinants of right ventricular outflow tract conduit longevity: a multinational analysis.

Authors:  Marieke B A Niemantsverdriet; Jaap Ottenkamp; Kimberlee Gauvreau; Pedro J Del Nido; Mark G Hazenkamp; Kathy J Jenkins
Journal:  Congenit Heart Dis       Date:  2008 May-Jun       Impact factor: 2.007

View more
  2 in total

1.  0.1 mm ePTFE versus autologous pericardium for hand-sewn trileaflet valved conduit: a comparative study.

Authors:  Huifeng Zhang; Ming Ye; Gang Chen; Bing Jia
Journal:  J Artif Organs       Date:  2019-06-01       Impact factor: 1.731

Review 2.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.